Trevi Therapeutics
Stock Forecast, Prediction & Price Target

Trevi Therapeutics (TRVI) stock Price Target by analysts

Last Year
Average Price Target

$6

Potential downside: -18.14%

Based on 2 analysts

Trevi Therapeutics price prediction

Strike.market

What is Trevi Therapeutics stock analysts` prediction?

Trevi Therapeutics stock forecast: Based on 2 Wall Street analysts` predicted price targets for Trevi Therapeutics in the last 3 months, the avarage price target is $6, with a high forecast of $NaN. The average price target represents a -18.14% change from the last price of $7.33.

Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.

Trevi Therapeutics stock Price Target by analysts

Full breakdown of analysts given Trevi Therapeutics price targets

Analyst name & company
Analyst win rate
Publish date
 Price target
Price when posted
 Source Historical targets
Oren Livnat
H.C. Wainwright
0%
0/1
 11 months ago $6 -18.14% downside $3.35 StreetInsider
Previous targets (0)
Mayank Mamtani
B.Riley Financial
0%
0/1
 11 months ago $6 -18.14% downside $3.02 StreetInsider
Previous targets (0)
Leland Gershall
Oppenheimer
0%
0/1
 about 3 years ago $12 63.71% upside $3.95 Pulse 2.0
Previous targets (0)
Serge Belanger
Needham
0%
0/1
 about 3 years ago $10 36.42% upside $2.45 TheFly
Previous targets (0)
Leland Gershell
Oppenheimer
0%
0/1
 over 3 years ago $10 36.42% upside $2.2 Pulse 2.0
Previous targets (0)

Trevi Therapeutics Financial Estimates

Trevi Therapeutics Revenue Estimates

Trevi Therapeutics EBITDA Estimates

Trevi Therapeutics Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $1.18M
Low: $1.18M
High: $1.18M
avg. 0%
Avg: $12.23M
Low: $12.23M
High: $12.23M
avg. 936.45%
Avg: $113.25M
Low: $113.25M
High: $113.25M
avg. 826.03%
Net Income
 
% change YoY
$-33.94M
 
N/A
$-29.15M
 
14.10%
$-29.06M
 
0.29%
Avg: $-53.5M
Low: $-61.40M
High: $-37.63M
avg. -84.07%
Avg: $-79.1M
Low: $-87.14M
High: $-49.51M
avg. -47.85%
Avg: $-70.90M
Low: $-70.90M
High: $-70.90M
avg. 10.35%
Avg: $-12.28M
Low: $-12.28M
High: $-12.28M
avg. 82.68%
EBITDA
 
% change YoY
$-32.79M
 
N/A
$-29.90M
 
8.79%
$-33.8M
 
-13.01%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$1.49
 
N/A
-$0.45
 
69.79%
-$0.29
 
35.55%
Avg: -$0.46
Low: -$0.62
High: -$0.38
avg. -58.62%
Avg: -$0.68
Low: -$0.88
High: -$0.5
avg. -48.54%
Avg: -$0.72
Low: -$0.72
High: -$0.72
avg. -4.78%
Avg: -$0.12
Low: -$0.12
High: -$0.12
avg. 82.68%
Operating Expenses
 
% change YoY
$32.47M
 
N/A
$29.90M
 
-7.91%
$33.92M
 
13.42%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Trevi Therapeutics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of -9.72% in 2025-2028.

We have gathered data from 4 analysts. Their low estimate is -61.40M, average is -53.5M and high is -37.63M.

What is Trevi Therapeutics stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 440.62% in 2025-2028.

We have gathered data from 5 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.

What is Trevi Therapeutics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of -7.31% in 2025-2028.

We have gathered data from 4 analysts. Their low earnings per share estimate is -$0.62, average is -$0.46 and high is $-0.38.

What is the best performing analyst?

In the last twelve months 2 analysts have been covering Trevi Therapeutics stock. The most successful analyst is Oren Livnat.